• We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need optimized assays for investigational toxicology.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon

Combining HUB Organoids™ with Organ-on-a-Chip Technology: the Best of Two Worlds

On-Demand Webinar

The transition from 2D to 3D cell culture is a first step towards physiologically more relevant in vitro models for human (disease) modeling and preclinical drug development. Organoid and Organ-on-a-Chip technology are two fields of development that are rapidly redefining cell culture biology in the 21st century. HUB Organoids™ are excellent surrogates of patients, capable of taking on the function of the tissue of origin and modeling a wide range of diseases in the areas of oncology, infectiology, genetics and metabolism. Organ-on-a-Chip technology has demonstrated how microengineering can add aspects such as perfusion flow, patterning of tissues, extracellular matrix embedment, vascular structure, precise control over gradients and application of mechanical strain to tissue culture.

In this webinar, scientists from MIMETAS and Hubrecht Organoid Technology (HUB) will give you an introduction of HUB Organoids™, and the OrganoPlate® platform. You will learn how a combination of both technologies can be used for in vitro tissue- and disease modeling.

In this webinar, you will learn:

  • Why HUB Organoids™ in OrganoPlate® have a great potential for early drug discovery and development
  • Why combining organoids with organ-on-a-chip technology open new doors for (complex) tissue- and disease modelling
  • Which applications combine the best of these two worlds and will inspire your research

Register Here


May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy
Accept all
Accept selected
Decline all